CLINICAL_TRIALS
trial_result
· 2017-12-02
Clinical Trial Update: Trial of Oral Valproic Acid for Retinitis Pigmentosa [Phase 2]
Summary
Phase 2 trial evaluating oral valproic acid for Retinitis Pigmentosa has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Foundation Fighting Blindness | Conditions: Retinitis Pigmentosa | Phase 2 | Status: COMPLETED | Results posted: 2017-12-02